Your browser doesn't support javascript.
loading
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials.
Cremolini, C; Loupakis, F; Masi, G; Lonardi, S; Granetto, C; Mancini, M L; Chiara, S; Moretto, R; Rossini, D; Vitello, S; Allegrini, G; Tonini, G; Bergamo, F; Tomasello, G; Ronzoni, M; Buonadonna, A; Bustreo, S; Barbara, C; Boni, L; Falcone, A.
Afiliação
  • Cremolini C; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa.
  • Loupakis F; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa.
  • Masi G; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa.
  • Lonardi S; Unit of Medical Oncology 1, Istituto Oncologico Veneto, IRCSS, Padua.
  • Granetto C; Unit of Medical Oncology, Azienda Sanitaria Ospedaliera Santa Croce e Carle, Cuneo.
  • Mancini ML; Department of Medical Oncology, University of Rome La Sapienza, Rome.
  • Chiara S; Department of Medical Oncology 2, IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa.
  • Moretto R; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa.
  • Rossini D; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa.
  • Vitello S; Unit of Oncology, Sant'Elia Hospital, Caltanissetta.
  • Allegrini G; Unit of Medical Oncology, 'Felice Lotti' Hospital, Pontedera.
  • Tonini G; Department of Medical Oncology, University Campus Biomedico, Rome.
  • Bergamo F; Unit of Medical Oncology 1, Istituto Oncologico Veneto, IRCSS, Padua.
  • Tomasello G; Division of Medicine and Medical Oncology, Azienda Istituti Ospitalieri, Cremona.
  • Ronzoni M; Department of Oncology, 'San Raffaele' Hospital IRCSS, Milan.
  • Buonadonna A; Division of Oncology, Centro di Riferimento Oncologico, Aviano.
  • Bustreo S; ColoRectal Cancer Unit, Unit of Oncology 1, 'Molinette' Hospital, Città della Salute e della Scienza, Turin.
  • Barbara C; Unit of Medical Oncology, Spedali Riuniti di Livorno, Livorno.
  • Boni L; Clinical Trials Coordinating Center, Istituto Toscano Tumori, Florence, Italy.
  • Falcone A; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa alfredo.falcone@med.unipi.it.
Ann Oncol ; 27(5): 843-9, 2016 05.
Article em En | MEDLINE | ID: mdl-26861604
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article